$title = urlencode(the_title());?>
Upcoming Events
_____________________________________________________________________
SMi’s 5th Annual Biosimilars North America Conference
November 14-15, 2018
Venable Fitzpatrick is attending SMi’s 5th Annual Biosimilars North America Conference in New Jersey on November 14-15, 2018. Ha Kung Wong and Christopher Loh will be speaking at the conference.
BIO IPCC Fall Conference
November 14-16, 2018
Venable Fitzpatrick is attending BIO IPCC’s Fall Conference in Indiana on November 14-16, 2018. Ha Kung Wong, Robert Schwartz, and Corinne Atton will be speaking at the conference.
Corinne Atton has experience litigating cases concerning a wide range of pharmaceuticals and biotechnology, including DNA sequences, DNA sequencing technologies, recombinant polypeptides, enzyme inhibitors, and antidiabetic drugs. She has a B.Sc. honors degree in Human Genetics.
Christopher Loh has extensive experience counseling clients and litigating matters involving biotechnology and life sciences, including in the areas of antibody biosimilars, targeted cancer therapies, diabetes treatments and siRNA technologies. Christopher has a B.S. in Molecular Biochemistry and Biophysics and in Economics from Yale University.
Bob Schwartz has extensive experience litigating biotechnology and pharmaceutical patents, including those relating to antibodies, protein biochemistry, molecular biology, genomics and proteomics. Bob has a B.S. in Biology and a Ph.D. in Biochemistry. As a Principal Investigator of grant-funded research he published more than 40 articles in peer-reviewed publications and 7 book chapters.
Ha Kung Wong has extensive experience litigating a wide variety of pharmaceutical cases, including those concerning biologics used to treat rheumatoid arthritis and autoimmune disorders. He also has extensive experience consulting, conducting due diligence and licensing pharmaceutical portfolios. Ha Kung has a B.S. in Biochemistry and a B.S. in Chemistry.